$FBIO 3 SEC Filings

Filed On	Filing
03 Jan 2025	Form 3: Fortress Biotech, Inc., 10% owner · Avenue Therapeutics Inc Holds 294,800 shares of COMMON STOCK, PAR VALUE $0.0001
03 Jan 2025	Form 3: Fortress Biotech, Inc., 10% owner · Mustang Bio Inc Holds 6,552,784 shares of COMMON STOCK, PAR VALUE $0.0001
31 May 2024	Form 3: Fortress Biotech, Inc., 10% owner · Journey Medical Corp Holds 4,110,467 shares of COMMON STOCK, PAR VALUE $0.0001
24 May 2024	Form 3: Fortress Biotech, Inc., 10% owner · Checkpoint Therapeutics, Inc. Holds 3,589,193 shares of COMMON STOCK, PAR VALUE $0.0001
19 Dec 2022	Form 3: Lu Lucy, Director Holds 36,403 shares of Common Stock
25 Aug 2022	Form 3: Jin David, Chief Financial Officer Holds 47,829 shares of Common Stock
10 Dec 2019	Form 3: Lorenz Kevin, Director Holds 30,000 shares of Common Stock, par value $0.001
19 Oct 2017	Form 3: Hunter Robyn, Chief Financial Officer Holds 260,129 shares of Common Stock (Restricted)
23 Aug 2017	Form 3: Fortress Biotech, Inc., 10% owner · Avenue Therapeutics Inc Holds 3,316,259 shares of Common Stock
07 Jun 2017	Form 3: Fortress Biotech, Inc., 10% owner · Mustang Bio Inc Holds 9,000,000 shares of Common Stock, par value $0.0001
07 Jun 2017	Form 3: Fortress Biotech, Inc., 10% owner · Checkpoint Therapeutics, Inc. Holds 1,981,006 shares of Common Stock, $0.0001 par value
22 Sep 2016	Form 3: Fbio Acquisition, Inc., 10% owner and 5 others · NATIONAL HOLDINGS CORP Holds 7,037,482 shares of Common Stock
17 Jul 2015	Form 3: Klein Dov, Director Holds 5,000 shares of Common Stock, par value $0.001
12 Dec 2014	Form 3: Rosenwald Lindsay A Md, Director and 1 other · Origo Acquisition Corp Holds 1,385,000 shares of Ordinary Shares
24 Feb 2014	Form 3: Hoenlein Malcolm, Director Holds 0 shares of No securities beneficially owned
23 Dec 2013	Form 3: Weiss Michael S, Director Holds 0 shares of No securities beneficially owned
06 Nov 2013	Form 3: Horgan Kevin, Chief Medical Officer Holds 0 shares of No securities beneficially owned
06 Jun 2013	Form 3: Avgerinos George, SVP, Biologics Operations Holds 8,000 shares of Common Stock, par value $0.001
20 Aug 2012	Form 3: Weisman Harlan F, Director
26 Jun 2012	Form 3: Elliott INTERNATIONAL, L.p., 10% owner Holds 1,654,898 shares of Common Stock

Comments